Renal Transplantation Flashcards

1
Q

What is the criteria for initiating renal replacement therapy (RRT)?

A

GFR < 10mL/min + symptomatic

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

At what level of renal function should a patient meet with the transplantation team

A

GFR < 20ml/min

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What are absolute contraindications to renal transplantation?

A
  1. Unable to adhere to medication regimen
  2. Active infection
  3. Active malignancy
  4. Mentally challenged
  5. Reversible cause of renal failure
  6. High probability of peri-operative mortality
  7. Anatomic issues (significant vascular disease)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What renal diseases have a high risk of recurring in the transplanted kidney?

A
  1. FSGS
  2. Hemolytic uremic syndrome
  3. Membranoproliferative glomerulonephritis
  4. Primary Oxalosis
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What renal diseases have an intermediate risk of recurring in the transplanted kidney?

A
  1. Sickle cell
  2. Amyloidosis
  3. Fabry disease
  4. IGA nephropathy
  5. HTN nephropathy
  6. Diabetic Nephropathy
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What renal diseases do NOT recur in a transplanted kidney?

A
  1. ADPCKD
  2. Cystinosis
  3. Renal dysplasia
  4. Alport syndrome (without anti-GBM antibodies)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

How do you manage malignancy in transplant candidates?

A

Need to ensure disease cure, with disease free period dependent on type of CA. Oncology consults should be obtained to determine risk of recurrence, surveillance and long term prognosis. Patients should be screened for malignancy appropriate to age and gender

Melanoma - 5 years
Any metastatic malignancy - 5 years
High grade, invasive urothelial CA - 5 years
Any localized malignancy - 2 years

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

When is cholecystectomy advised prior to receiving a transplant?

A
  1. Gallbladder polyps greater than 1cm

2. Patients with diabetes and gallstones (increased morbidity in acute cholecystitis after transplantation)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What should a patient be assessed for prior to transplantation?

A
  1. Peripheral vascular system (claudication, past vascular procedures, femoral pulses) - if concerns doppler U/S or CT to assess
  2. Abdominal exam for surgical scars and information about past surgical history
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What are the indications for a pre-transplant nephrectomy?

A
  1. Symptomatic renal stones not cleared by minimally invasive techniques or lithotripsy
  2. Polycystic kidneys that are symptomatic, extend below the iliac crest, have been infected or have solid tumors.
  3. Persistent anti-GBM antibody levels
  4. Significant proteinuria not controlled with medical nephrectomy or angioablation
  5. Recurrent pyelonephritis, or chronically infected kidney
  6. Grade 4 or 5 VUR with urinary tract infections
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

How should bladder outlet obstruction be managed in the transplant patient?

A

First line: medical management - alpha blockers and 5-alpha reductase inhibitors

Second line: TURP = should NOT be performed in anuric/oliguric patients as high risk contracture and strictures

Third line: CIC or indwelling catheterization

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What are the guidelines for determination of neurologic death? (DND kidney)

A
  1. Complete cessation of all brain stem function (must be irreversible)
    Determined by coma + absence of brainstem reflexes
  2. Apnea challenge
    Determined by no respiratory effort at PaCo2 60 or greater
  3. Negative confirmatory tests if doubt exists.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What are the criteria for donation after circulatory death (DCD)?

A
  1. Donor does not meet neurologic death criteria, despite being comatose
  2. Decision made by family to withdraw cardio-pulmonary support.
  3. Death declared by absence of spontaneous respiration and sustained systole for 5 minutes.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What are the steps in the harvest of organs from a deceased donor?

A
  1. Median sternotomy and midline incision
  2. Organ inspection for signs of disease
  3. Vascular control - above and below organs for donation
  4. Cannulas inserted for the administration of preservation solution inserted into aorta, clamps are applied, venous effluent is vented and organs are flushed.
  5. Organs are extirpated.
  6. Immediately are cooled with slush once removed.
  7. Spleen and lymph node sections removed for histocompatibility.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

How are kidneys preserved once extirpated?

A
  1. Hypothermia (4C) reduces energy expenditure
  2. Pulsatile preservation pumps may reduce vascular spasm
  3. Preservation solution (wisconsin solution) designed to maintain intracellular electrolyte composition
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What are the contents of Wisconsin solution?

A

K lactobionate, KH2PO4, MgSO4, Raffinose, Adenosine, Insulin, glutathione, dexamethasone, allopurinol, penicillin, potassium, sodium

17
Q

What are the four categories of kidney donors?

A
  1. Standard criteria donor younger than 35
  2. Standard criteria donor older than 35
  3. Expanded criteria donor
  4. Donation after circulatory death
18
Q

What are the criteria of an expanded criteria donor?

A
  1. Age over 60
  2. Age between 50-59 with 2 or more of (death from stroke, HTN, elevated Cr just before organ recovery (1.5mg/dL)

*ECD has 80% 2 year graft survival versus 88% for SCD)

19
Q

What happens in ABO incompatibility?

A

Acute rejection - antibodies bind to perceived antigen, trigger complement cascade, leading to coagulation, thrombosis and rapid graft loss.

20
Q

What two classes of HLA’s are used in kidney allocation

A

HLA Class I (HLA-A, HLA-B, HLA-C)
- expressed by all nucleated cells through MHC
HLA Class II (HLA-DR, HLA-DQ, HLA-DP)
-Expressed by antigen presenting cells (dendritic cells, monocytes, macrophages, and B-lymphocytes)

21
Q

What increases the risk of antibody and cellular rejection?

A
  1. Pregnancy
  2. Blood transfusion
  3. Prior transplantation
  4. Some infections

These things increase risk of forming HLA antibodies
individuals with antibodies directed at 20% of population are said to be sensitized
highly sensitized if antibodies directed at 80% of the population.

22
Q

What are the three classes of renal rejection?

A
  1. Hyperacute - immediate (ABO incompatibility)
  2. Acute - 5 days after allogenic transplant (cellular +/- Ab bx to determine
  3. Chronic - gradual deterioration (vascular
23
Q

What are contraindications to donation of a kidney?

A
  1. Renal disease (GFR < 80)
  2. Transmissible infection
  3. Active malignancy
  4. Mental disorder (incompetent)
  5. High operative risk
  6. Minor
  7. Anatomic unfeasibility
24
Q

What are the indications for dialysis

A
  1. Acidosis (metabolic)
  2. Electrolytes (hyper-K)
  3. Intoxicants
  4. Volume overload
  5. Uremia (pericarditis, pericardial effusion)
25
Q

What is the differential diagnosis of a fluid collection found post-operatively from a renal transplant

A
  1. Seroma
  2. Lymphocele
  3. Abscess
  4. Hematoma
  5. Urinoma
26
Q

When should you intervene in a post-operative renal transplant fluid collection?

A
  1. Fever
  2. Pain
  3. Obstruction
  4. If may be contributing to decreased renal function
27
Q

List causes of early graft dysfunction?

A
  1. ATN
  2. Calcineurin inhibitor toxicity
  3. Rejection
  4. Infection
  5. Obstruction
  6. Hyperglycemia
28
Q

What is the definition of delayed graft function?

A

Requirement for dialysis during the first week of transplantation.

29
Q

What are the classes of immunosuppressants and how do they work?

A
  1. Antiproliferative agents (azathioprine, and MMF) - Block DNA/RNA prodction
  2. Calcineurin inhibitors (cyclosporin and tacrolimus) - inhibit T-cell activation
  3. Monoclonal antibodies (Anti-CD25, basiliximab, daclizumab) - block IL2 receptor
  4. Rapamycin - mTOR inhibitor
  5. Corticosteroids - inhibit gene transcription and IL2 activity